Major histocompatibility complex class II—T cell receptor complex (MHC class II–TCR complex)

The **major histocompatibility complex class II–T cell receptor complex** refers to the molecular assembly formed when a peptide antigen, presented by MHC class II molecules (on antigen-presenting cells), is recognized by the T cell receptor (TCR) primarily on CD4+ helper T cells. MHC class II molecules, expressed mainly on dendritic cells, macrophages, and B cells, present peptides derived from extracellular proteins, which occupy a broad groove on the MHC molecule[1][4][7]. The TCR, typically an αβ heterodimer, docks diagonally onto the peptide–MHC surface, making specific contacts with both the presented peptide and conserved regions of the MHC[7][9][10]. This interaction is central to the adaptive immune response: it initiates signaling required for helper T cell activation, cytokine production, and coordination of further immune effector functions[1][4][6]. Aberrant or dysregulated recognition may contribute to autoimmune diseases, infection susceptibility, transplant rejection, and is a central target in modulation for immunotherapies. While no approved drugs directly target the complex itself (due to extreme risk of global immune suppression), agents such as abatacept modulate co-stimulatory signals adjacent to this recognition event and are used in autoimmune disease and transplantation settings.

Other names

MHC class II–TCRpMHC-II–TCRpeptide–MHC class II–T cell receptorMHC-II/TCRpeptide-MHC II/TCRMHC-II/TCR complex

Inhibition of T cell activation (by blocking co-stimulation rather than the direct MHC-TCR interface); Anti-inflammatory (for drugs targeting downstream effects).